9Mon·

Purchases this week

I'll cautiously set foot in the door at $GSIT a cautious foot in the door. Here, however, profit-taking could encourage better entries (for additional buying).

In addition to my Nektar $NKTR (-5.41%) position, I want to expand my biotech/health field. With Tempus $TEM (-7.48%) and the @BamBamInvest value Procept $PRCT.

05.01

GSI Technology

Bought at $6.73

6 Comments

Chris@Multibagger

9Mon

Apart from $GSIT, I have them all.

•

Darkwingduck@Darkwingduck

9Mon

@Multibagger nectar, I'm really excited. It's almost an all or nothing bet. If the 52-week study disappoints, you have to win the lawsuit against Eli Lilly for a second Versuch😵‍💫 but I'm in good spirits

•

Chris@Multibagger

9Mon

@Darkwingduck I think it will at least double this year.

••

Darkwingduck@Darkwingduck

9Mon

@Multibagger If the study is good, then Lutzi will really take off. They will then enter markets worth several billion euros (Dupixent, Rinvoq).

•

Darkwingduck@Darkwingduck

9Mon

@Multibagger Have you heard of $LCTX? They've partnered with Roche $ROG for their studies.

•

Chris@Multibagger

9Mon

@Darkwingduck never heard

••